Expert consensus on Dual Antiplatelet Therapy (DAPT) for acute coronary syndrome in Thailand: Review article
© JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND | 2019. Acute coronary syndrome (ACS) is an emergency condition that may lead to severe morbidity or mortality. One factor that may improve mortality in ACS is dual antiplatelet therapy (DAPT) with a P2Y12 receptor blocker on top of aspirin. Recently,...
Saved in:
Main Authors: | R. Kunjara-Na-Ayudhya, W. Buddhari, B. Sookananchai, S. Kuanprasert, N. Chamnarnphol, A. Sukonthasarn |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076499856&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/68013 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Evolving Antiplatelet Treatment, Will the New Agent Change Clinical Practice for All Acute Coronary Syndrome?
by: Rosi Amrilla F, -, et al.
Published: (2012) -
Cost-effectiveness of CYP2C19-guided antiplatelet therapy for acute coronary syndromes in Singapore
by: Kim, Ji Heon, et al.
Published: (2021) -
Evidence of influenza or influenza-like-illness preceding acute coronary syndrome
by: Kuanprasert S., et al.
Published: (2014) -
Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome
by: Phrommintikul A., et al.
Published: (2014) -
Evidence of influenza or influenza-like-illness preceding acute coronary syndrome
by: Srun Kuanprasert, et al.
Published: (2018)